This page shows the latest olaratumab news and features for those working in and with pharma, biotech and healthcare.
Dr Sue Mahony, president of Lilly Oncology, said: “ With this decision, olaratumab is now authorised for use in the EU, offering a new treatment option for soft tissue sarcoma patients in
The US FDA granted accelerated approval to Lartruvo (olaratumab) used in combination with doxorubicin chemotherapy in STS patients who cannot be cured using surgery or radiotherapy, and who have a form
The EMA panel gave a green light to a conditional approval of Lartruvo (olaratumab), used in combination with doxorubicin chemotherapy, for advanced STS patients who cannot be treated with surgery or ... Olaratumab is also under regulatory review in the
Top projects include PDGF inhibitor olaratumab, which was granted priority review by the FDA earlier this month for soft tissue sarcoma, and CDK4/6 inhibitor abemaciclib for advanced breast cancer and ... Olaratumab will see its first marketing
More from news
Approximately 2 fully matching, plus 2 partially matching documents found.
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....